Joint protection strategies help prevent the chronic arthritis that historically plagued hemophilia patients. Proper body mechanics, assistive devices when needed, maintaining healthy weight ...

A person with hemophilia A can live a relatively normal ... These problems can compound over time and develop into arthritis. People who develop severe joint damage may need joint replacement ...

(1) The knee and ankles are the most likely joints to be affected. Over time, a person with hemophilia may develop arthritis or other types of joint pain or conditions that make it harder to walk ...

Hemophilia is a rare inherited disorder characterized ... In rheumatic diseases such as osteoarthritis or rheumatoid arthritis, NSAIDs are mainstays for managing chronic joint pain and inflammation.

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Hemophilia B is a rare X-chromosome-linked ... However, this approach does not prevent debilitating arthritis and joint damage due to chronic inflammation of the synovial lining when blood ...

Hemophilia is a rare bleeding disorder characterized by low levels of proteins called “clotting factors.” Hemophilia is an inherited blood disorder in which your blood does not clot properly ...

Hepatitis C and Hemophilia Before routine and effective ... But true rheumatoid arthritis is uncommon in people with hepatitis C virus.

For centuries, hemophilia was a dangerous genetic disorder with no treatment. Children with hemophilia often didn't make it to adulthood, since a bump or fall could cause massive internal bleeding.

The FDA approved fitusiran (Qfitlia) as prophylaxis to prevent or reduce bleeding episodes in adults and children ages 12 years and up with hemophilia A or B, with or without factor VIII or IX ...